Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

Biotechnology Law Report, Ahead of Print.

Source: Biotechnology Law Report - March 12, 2021 Category: Medical Law Authors: Christopher M. Holman Source Type: research